Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic
Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesiv...
Gespeichert in:
| Veröffentlicht in: | International journal of immunopathology and pharmacology 2020, Vol.34, p.2058738420941754-2058738420941754 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2058738420941754 |
|---|---|
| container_issue | |
| container_start_page | 2058738420941754 |
| container_title | International journal of immunopathology and pharmacology |
| container_volume | 34 |
| creator | Ciorba, Andrea Corazzi, Virginia Skarżyński, Piotr Henryk Skarżyńska, Magdalena B Bianchini, Chiara Pelucchi, Stefano Hatzopoulos, Stavros |
| description | Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions. |
| doi_str_mv | 10.1177/2058738420941754 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7357052</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2058738420941754</sage_id><sourcerecordid>2473723022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-2249e895295dbc8fbd35c6abd1307282ee49298aafcb7bf96934b11e7e1664f63</originalsourceid><addsrcrecordid>eNp1kUtLAzEQgIMottTePS54qYfVvHazuQil9QUFwarXkM1mtyntpia7xd78G_49f4m7tPgoyBwyTL75MmEAOEXwAiHGLjGMEkYSiiGniEX0AHTbUtjWDn_lHdD3fg4hRJDQKEHHoENwTDmOcReMx7b8fP-ogty6QleBrZp4M8pUmyCrnSmLoJrpYDp8nIYj-xLiYDCya5OFiJ8HK1lmemnUCTjK5cLr_u7sgeeb66fRXTh5uL0fDSehooRXIcaU64RHmEdZqpI8zUikYplmiECGE6x1MxRPpMxVytKcx5zQFCHNNIpjmsekB6623lWdLnWmdFk5uRArZ5bSbYSVRvy9Kc1MFHYtGIkYjHAjGOwEzr7W2ldiabzSi4Usta29wBQTGFPK27fO9tC5rV3ZfK-hGGENiFsh3FLKWe-dzr-HQVC0WxL7W2pawm2Ll4X-kf7LfwEUz45d</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473723022</pqid></control><display><type>article</type><title>Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic</title><source>Sage Journals GOLD Open Access 2024</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ciorba, Andrea ; Corazzi, Virginia ; Skarżyński, Piotr Henryk ; Skarżyńska, Magdalena B ; Bianchini, Chiara ; Pelucchi, Stefano ; Hatzopoulos, Stavros</creator><creatorcontrib>Ciorba, Andrea ; Corazzi, Virginia ; Skarżyński, Piotr Henryk ; Skarżyńska, Magdalena B ; Bianchini, Chiara ; Pelucchi, Stefano ; Hatzopoulos, Stavros</creatorcontrib><description>Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.</description><identifier>ISSN: 2058-7384</identifier><identifier>ISSN: 0394-6320</identifier><identifier>EISSN: 2058-7384</identifier><identifier>DOI: 10.1177/2058738420941754</identifier><identifier>PMID: 32649262</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Antiretroviral drugs ; Antiviral agents ; Antiviral drugs ; Azithromycin ; Chloroquine ; Coronaviruses ; COVID-19 ; Hydroxychloroquine ; Letter to the Editor ; Lopinavir ; Ototoxicity ; Pandemics ; Severe acute respiratory syndrome coronavirus 2 ; Side effects</subject><ispartof>International journal of immunopathology and pharmacology, 2020, Vol.34, p.2058738420941754-2058738420941754</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020 2020 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-2249e895295dbc8fbd35c6abd1307282ee49298aafcb7bf96934b11e7e1664f63</citedby><cites>FETCH-LOGICAL-c439t-2249e895295dbc8fbd35c6abd1307282ee49298aafcb7bf96934b11e7e1664f63</cites><orcidid>0000-0003-3455-2295</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357052/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357052/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,21966,27853,27923,27924,27925,44945,45333,53791,53793</link.rule.ids></links><search><creatorcontrib>Ciorba, Andrea</creatorcontrib><creatorcontrib>Corazzi, Virginia</creatorcontrib><creatorcontrib>Skarżyński, Piotr Henryk</creatorcontrib><creatorcontrib>Skarżyńska, Magdalena B</creatorcontrib><creatorcontrib>Bianchini, Chiara</creatorcontrib><creatorcontrib>Pelucchi, Stefano</creatorcontrib><creatorcontrib>Hatzopoulos, Stavros</creatorcontrib><title>Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic</title><title>International journal of immunopathology and pharmacology</title><description>Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.</description><subject>Antiretroviral drugs</subject><subject>Antiviral agents</subject><subject>Antiviral drugs</subject><subject>Azithromycin</subject><subject>Chloroquine</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Hydroxychloroquine</subject><subject>Letter to the Editor</subject><subject>Lopinavir</subject><subject>Ototoxicity</subject><subject>Pandemics</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Side effects</subject><issn>2058-7384</issn><issn>0394-6320</issn><issn>2058-7384</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kUtLAzEQgIMottTePS54qYfVvHazuQil9QUFwarXkM1mtyntpia7xd78G_49f4m7tPgoyBwyTL75MmEAOEXwAiHGLjGMEkYSiiGniEX0AHTbUtjWDn_lHdD3fg4hRJDQKEHHoENwTDmOcReMx7b8fP-ogty6QleBrZp4M8pUmyCrnSmLoJrpYDp8nIYj-xLiYDCya5OFiJ8HK1lmemnUCTjK5cLr_u7sgeeb66fRXTh5uL0fDSehooRXIcaU64RHmEdZqpI8zUikYplmiECGE6x1MxRPpMxVytKcx5zQFCHNNIpjmsekB6623lWdLnWmdFk5uRArZ5bSbYSVRvy9Kc1MFHYtGIkYjHAjGOwEzr7W2ldiabzSi4Usta29wBQTGFPK27fO9tC5rV3ZfK-hGGENiFsh3FLKWe-dzr-HQVC0WxL7W2pawm2Ll4X-kf7LfwEUz45d</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Ciorba, Andrea</creator><creator>Corazzi, Virginia</creator><creator>Skarżyński, Piotr Henryk</creator><creator>Skarżyńska, Magdalena B</creator><creator>Bianchini, Chiara</creator><creator>Pelucchi, Stefano</creator><creator>Hatzopoulos, Stavros</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3455-2295</orcidid></search><sort><creationdate>2020</creationdate><title>Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic</title><author>Ciorba, Andrea ; Corazzi, Virginia ; Skarżyński, Piotr Henryk ; Skarżyńska, Magdalena B ; Bianchini, Chiara ; Pelucchi, Stefano ; Hatzopoulos, Stavros</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-2249e895295dbc8fbd35c6abd1307282ee49298aafcb7bf96934b11e7e1664f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antiretroviral drugs</topic><topic>Antiviral agents</topic><topic>Antiviral drugs</topic><topic>Azithromycin</topic><topic>Chloroquine</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Hydroxychloroquine</topic><topic>Letter to the Editor</topic><topic>Lopinavir</topic><topic>Ototoxicity</topic><topic>Pandemics</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ciorba, Andrea</creatorcontrib><creatorcontrib>Corazzi, Virginia</creatorcontrib><creatorcontrib>Skarżyński, Piotr Henryk</creatorcontrib><creatorcontrib>Skarżyńska, Magdalena B</creatorcontrib><creatorcontrib>Bianchini, Chiara</creatorcontrib><creatorcontrib>Pelucchi, Stefano</creatorcontrib><creatorcontrib>Hatzopoulos, Stavros</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of immunopathology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ciorba, Andrea</au><au>Corazzi, Virginia</au><au>Skarżyński, Piotr Henryk</au><au>Skarżyńska, Magdalena B</au><au>Bianchini, Chiara</au><au>Pelucchi, Stefano</au><au>Hatzopoulos, Stavros</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic</atitle><jtitle>International journal of immunopathology and pharmacology</jtitle><date>2020</date><risdate>2020</risdate><volume>34</volume><spage>2058738420941754</spage><epage>2058738420941754</epage><pages>2058738420941754-2058738420941754</pages><issn>2058-7384</issn><issn>0394-6320</issn><eissn>2058-7384</eissn><abstract>Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>32649262</pmid><doi>10.1177/2058738420941754</doi><orcidid>https://orcid.org/0000-0003-3455-2295</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2058-7384 |
| ispartof | International journal of immunopathology and pharmacology, 2020, Vol.34, p.2058738420941754-2058738420941754 |
| issn | 2058-7384 0394-6320 2058-7384 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7357052 |
| source | Sage Journals GOLD Open Access 2024; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Antiretroviral drugs Antiviral agents Antiviral drugs Azithromycin Chloroquine Coronaviruses COVID-19 Hydroxychloroquine Letter to the Editor Lopinavir Ototoxicity Pandemics Severe acute respiratory syndrome coronavirus 2 Side effects |
| title | Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A34%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Don%E2%80%99t%20forget%20ototoxicity%20during%20the%20SARS-CoV-2%20(Covid-19)%20pandemic&rft.jtitle=International%20journal%20of%20immunopathology%20and%20pharmacology&rft.au=Ciorba,%20Andrea&rft.date=2020&rft.volume=34&rft.spage=2058738420941754&rft.epage=2058738420941754&rft.pages=2058738420941754-2058738420941754&rft.issn=2058-7384&rft.eissn=2058-7384&rft_id=info:doi/10.1177/2058738420941754&rft_dat=%3Cproquest_pubme%3E2473723022%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473723022&rft_id=info:pmid/32649262&rft_sage_id=10.1177_2058738420941754&rfr_iscdi=true |